125 related articles for article (PubMed ID: 16601124)
21. IL-6 mediated activation of STAT3 bypasses Janus kinases in terminally differentiated B lineage cells.
Kopantzev Y; Heller M; Swaminathan N; Rudikoff S
Oncogene; 2002 Oct; 21(44):6791-800. PubMed ID: 12360405
[TBL] [Abstract][Full Text] [Related]
22. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes.
Pan J; Fukuda K; Saito M; Matsuzaki J; Kodama H; Sano M; Takahashi T; Kato T; Ogawa S
Circ Res; 1999 May; 84(10):1127-36. PubMed ID: 10347087
[TBL] [Abstract][Full Text] [Related]
23. TWEAK signals through JAK-STAT to induce tumor cell apoptosis.
Chapman MS; Wu L; Amatucci A; Ho SN; Michaelson JS
Cytokine; 2013 Jan; 61(1):210-7. PubMed ID: 23107828
[TBL] [Abstract][Full Text] [Related]
24. Deucravacitinib, a tyrosine kinase 2 pseudokinase inhibitor, protects human EndoC-βH1 β-cells against proinflammatory insults.
Dos Santos RS; Guzman-Llorens D; Perez-Serna AA; Nadal A; Marroqui L
Front Immunol; 2023; 14():1263926. PubMed ID: 37854597
[TBL] [Abstract][Full Text] [Related]
25. CTLA4 Promotes Tyk2-STAT3-Dependent B-cell Oncogenicity.
Herrmann A; Lahtz C; Nagao T; Song JY; Chan WC; Lee H; Yue C; Look T; Mülfarth R; Li W; Jenkins K; Williams J; Budde LE; Forman S; Kwak L; Blankenstein T; Yu H
Cancer Res; 2017 Sep; 77(18):5118-5128. PubMed ID: 28716895
[TBL] [Abstract][Full Text] [Related]
26. Activation of mitogen-activated protein kinase kinase (MKK) 3 and MKK6 by type I interferons.
Li Y; Batra S; Sassano A; Majchrzak B; Levy DE; Gaestel M; Fish EN; Davis RJ; Platanias LC
J Biol Chem; 2005 Mar; 280(11):10001-10. PubMed ID: 15644321
[TBL] [Abstract][Full Text] [Related]
27. Major differences in the responses of primary human leukocyte subsets to IFN-beta.
van Boxel-Dezaire AH; Zula JA; Xu Y; Ransohoff RM; Jacobberger JW; Stark GR
J Immunol; 2010 Nov; 185(10):5888-99. PubMed ID: 20956346
[TBL] [Abstract][Full Text] [Related]
28. Down-modulation of type 1 interferon responses by receptor cross-competition for a shared Jak kinase.
Dondi E; Pattyn E; Lutfalla G; Van Ostade X; Uzé G; Pellegrini S; Tavernier J
J Biol Chem; 2001 Dec; 276(50):47004-12. PubMed ID: 11602573
[TBL] [Abstract][Full Text] [Related]
29. Tyrosine kinase 2 interacts with the proapoptotic protein Siva-1 and augments its apoptotic functions.
Shimoda HK; Shide K; Kameda T; Matsunaga T; Shimoda K
Biochem Biophys Res Commun; 2010 Sep; 400(2):252-7. PubMed ID: 20727854
[TBL] [Abstract][Full Text] [Related]
30. Histone deacetylase activity is required to recruit RNA polymerase II to the promoters of selected interferon-stimulated early response genes.
Sakamoto S; Potla R; Larner AC
J Biol Chem; 2004 Sep; 279(39):40362-7. PubMed ID: 15194680
[TBL] [Abstract][Full Text] [Related]
31. Role of STAT3 in type I interferon responses. Negative regulation of STAT1-dependent inflammatory gene activation.
Ho HH; Ivashkiv LB
J Biol Chem; 2006 May; 281(20):14111-8. PubMed ID: 16571725
[TBL] [Abstract][Full Text] [Related]
32. Requirement of catalytically active Tyk2 and accessory signals for the induction of TRAIL mRNA by IFN-beta.
Rani MR; Pandalai S; Shrock J; Almasan A; Ransohoff RM
J Interferon Cytokine Res; 2007 Sep; 27(9):767-79. PubMed ID: 17892398
[TBL] [Abstract][Full Text] [Related]
33. Novel functions of tyrosine kinase 2 in the antiviral defense against murine cytomegalovirus.
Strobl B; Bubic I; Bruns U; Steinborn R; Lajko R; Kolbe T; Karaghiosoff M; Kalinke U; Jonjic S; Müller M
J Immunol; 2005 Sep; 175(6):4000-8. PubMed ID: 16148148
[TBL] [Abstract][Full Text] [Related]
34. Hapten-induced contact hypersensitivity is enhanced in Tyk2-deficient mice.
Hosogi M; Tonogaito H; Aioi A; Hamada K; Shimoda K; Muromoto R; Matsuda T; Miyachi Y
J Dermatol Sci; 2004 Oct; 36(1):51-6. PubMed ID: 15488705
[TBL] [Abstract][Full Text] [Related]
35. Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor alpha chain 1: redundancy of requirement of tyrosine residue for STAT3 activation.
Umeshita-Suyama R; Sugimoto R; Akaiwa M; Arima K; Yu B; Wada M; Kuwano M; Nakajima K; Hamasaki N; Izuhara K
Int Immunol; 2000 Nov; 12(11):1499-509. PubMed ID: 11058569
[TBL] [Abstract][Full Text] [Related]
36. Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell.
Ho LJ; Hung LF; Weng CY; Wu WL; Chou P; Lin YL; Chang DM; Tai TY; Lai JH
J Immunol; 2005 Jun; 174(12):8163-72. PubMed ID: 15944325
[TBL] [Abstract][Full Text] [Related]
37. Vanadate facilitates interferon alpha-mediated apoptosis that is dependent on the Jak/Stat pathway.
Gamero AM; Larner AC
J Biol Chem; 2001 Apr; 276(17):13547-53. PubMed ID: 11278370
[TBL] [Abstract][Full Text] [Related]
38. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
39. Induction of beta-R1/I-TAC by interferon-beta requires catalytically active TYK2.
Rani MR; Gauzzi C; Pellegrini S; Fish EN; Wei T; Ransohoff RM
J Biol Chem; 1999 Jan; 274(4):1891-7. PubMed ID: 9890942
[TBL] [Abstract][Full Text] [Related]
40. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
Schaber JD; Fang H; Xu J; Grimley PM; Rui H
Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
